Dr. Lori Gore-Green | Women's Health Professional

Dr. Lori Gore-Green's Portfolio of Experience as a Women's Health Professional

Intermittent Fasting for Women: What to Know

by

For women struggling with weight loss, they may consider utilizing an intermittent fasting regime. This eating schedule is one of the world’s most popular weight-loss trends. Intermittent fasting is an eating pattern that cycles between patterns of eating and fasting. This eating plan does not dictate what foods to eat, instead of when is best to eat. However, intermittent fasting poses some serious risks for women. It is essential to be educated on the topic before considering implementing this eating schedule.

 

There are a few benefits of intermittent fasting. For example, it can boost fat burns. When people eat, blood sugar rises, and insulin is released to take the glucose to cells. Any leftover glucose is stored as fat. If intermittent someone fasts for 10-16 hours, their body will begin to burn its stored fat for energy. Other studies have found that fasting can repair cells, leading to increased longevity, a lowered risk of cancer, less inflammation, and improved metabolism. However, these studies are primarily conducted with animals rather than adult women. Other research suggests that eating in line with circadian rhythm, meaning eating only when it is light out, protects the body from chronic diseases.

 

On the other hand, research has identified many negative aspects of intermittent fasting. Women of reproductive age need to be especially mindful of putting stress on their body, as their body is particularly receptive to stressors like prolonged fasting and caloric restriction. Intermittent fasting may do more harm than good, as it can potentially lead to low blood sugar regulation, increased insulin resistance, and lean muscle loss, among other things. Additionally, prolonged underrating can seriously harm a women’s reproductive system. Women can potentially lose their menstrual cycle and interfere with their fertility. Moreover, fasting can increase someone’s hunger and obsession with food, thus leading to overeating or a process of restricting and binging.

 

Intermittent fasting has many positive features and many potential negative impacts on a woman’s body. Before starting an intermittent fasting regime, be sure to read up on the eating pattern and learn how to do it best. Women need to be knowledgeable and aware of any risks associated with intermittent fasting. Be sure to consult a doctor with any questions or concerns. 

Debate Over Gynecology Tool Sheds Light On Regulation

by

Dr. Lori Gore-GreenDoctors from all over the country are sticking by a gynecological tool even after a warning from the U.S. Food and Drug Administration about its ability to spread undetected cancer. As reported in a recent article from the Wall Street Journal, the face off between doctors and regulators is showcasing what some might call intransigence on the part of doctors, and others might call overreach on the part of the government. What is certainly clear is that quality gynecological care lies somewhere in the middle.

The device in question is called a laparoscopic power morcellator, and it is used by its proponents to remove benign uterine growths called fibroids. The tool is normally employed during routine hysterectomies to slice and remove the fibroids through small incisions. The issue with the morcellators is that they have the potential to leave tissue behind that can grow and then spread throughout the body, including tissue that has not been identified as malignant.

This potential threat prompted the warning from the FDA and caused many hospitals to stop using the tool, including Brigham and Women’s Hospital in Boston and Philadelphia’s Temple University Hospital. Many insurers across the country have stopped covering procedures involving morcellators.

However, there are gynecologists who believe that reports of the threat are unwarranted and continue to use the tool routinely. Doctors like Jeffrey Thurston of Dallas say that the treatments he performs with his patients are between he and his patient, and that regulators are simply interfering. In his practice, he has patients sign a release that states that the risk of spreading undetected sarcoma is somewhere between 1 in 300 and 1 and 1000. He also tells his patients verbally that he does not believe those numbers.

In the tug of war between the FDA and doctors, it can be difficult for patients to know whom to trust. Where one stands on the use of morcellators may have more to do with politics than any insights on patient welfare.

Read the whole story at Wall Street Journal.